DOI: https://doi.org/10.22141/2307-1257.8.2.2019.166667

Modality of renal replacement therapy and survival in the population of children with end-stage renal disease

S.V. Kushnirenko

Abstract


Background. Survival in the population of children with end-stage renal disease is multifactorial and depends on the diffe­rent characteristics of the patient and treatment, as well as on the degree of economic well-being of the country in which the treatment is taking place. While other patient-related aspects, such as growth, psychosocial development and quality of life, are important, extending patient survival is perhaps the most important clinical task. The aim of the study was to analyze the modality of renal replacement therapy and survival in the population of children with end-stage renal disease, based on a database of children in Kyiv who received renal replacement therapy from 2006 to 2018, using the example of the Kyiv Municipal Children’s Nephrology Centre. Materials and methods. In 40 children with chronic kidney disease stage 5 who received renal replacement therapy, modality of renal replacement therapy methods, primary renal diseases, gender and age characteristics, anthropometric data, glomerular filtration rate at the beginning of renal replacement therapy, residual kidney function, comorbidity and their effect on patients’ survival were analyzed. Results. Among 40 patients who started renal replacement therapy from 2006 to 2018 in Kyiv Municipal Children’s Nephro­logy Centre, the modality at baseline is represented by hemodialysis in 80 %, by preemptive kidney transplantation — in 12.5 %, by peritoneal dialysis — in 7.5 % of cases. The duration of renal replacement therapy ranged from 28 to 199 months. The majority of patients began treatment with hemodialysis at the age of 10–14 years (42.9 %). Kidney transplantation in children mainly occurred in 15–17 years (33.3 %). In total, the number of female patients on renal replacement therapy (hemodialysis and peritoneal dialysis) was 57.1 %, and that of men — 42.9 %. Among the patients with a transplanted kidney, 66.7 % are females and 33.3 % are males. In the majority of patients (> 50 %), primary renal diseases are represented by congenital anomalies of the kidney and the urinary tract; 10 % of children on renal replacement therapy had multiple congenital malformations (of the brain, heart, lungs), the syndromic diagnosis was recorded in 7.5 % of patients. Delayed psychomotor development was noted in 12.5 % of patients. Analysis of the obtained results showed that 48.6 % of children on hemodialysis and peritoneal dialysis were stunted, 51.4 % had arterial hypertension. With a glomerular filtration rate in the range of 8–15 ml/min/1.73 m2, 55 % of patients started treatment with renal replacement therapy. Conclusions. Survival of patients with end-stage renal disease is multifactorial, largely depends on access to treatment, health care costs in the country, etiology of the disease, age, sex, anthropometric parameters, the possibility of transplantation and the presence of concomitant diseases. Five-year survival rate of patients on renal replacement therapy for 2006–2018 in Kyiv Municipal Children’s Nephrology Centre was 93.1 %, 10-year survival rate — 83.3 %.


Keywords


renal replacement therapy; children; survival

References


Harambat J , van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol. 2012 Mar;27(3):363-73. doi: 10.1007/s00467-011-1939-1.

Chavers BM, Molony JT, Solid CA, Rheault MN, Collins AJ. One-year mortality rates in US children with end-stage renal disease. Am J Nephrol. 2015;41(2):121-8. doi: 10.1159/000380828.

Chesnaye N, Bonthuis M, Schaefer F, et al. Demographics of paediatric renal replacement therapy in Europe: A report of the ESPN/ERA-EDTA registry. Pediatr Nephrol. 2014 Dec;29(12):2403-10. doi: 10.1007/s00467-014-2884-6.

ESPN/ERA-EDTA. The new ESPN Registry. 2006. Available from: https://espn-reg.org/files/pd2006_espn__online.pdf. Accessed: August 2008.

ESPN/ERA-EDTA. An update on the Registry. 2008. Available from: https://espn-reg.org/files/pd2008_espn__online.pdf. Accessed: August 2010.

ESPN/ERA-EDTA. An update on the Registry. 2016. Available from: https://espn-reg.org/files/AR2016_final.pdf. Accessed: November 2018.

McDonald SP, Craig JC; Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N Engl J Med. 2004 Jun 24;350(26):2654-62. doi: 10.1056/NEJMoa031643.

Amaral S, Sayed BA, Kutner N, Patzer RE. Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease. Kidney Int. 2016 Nov;90(5):1100-1108. doi: 10.1016/j.kint.2016.07.028.

Korevaar JC, Feith GW, Dekker FW, et al; NECOSAD Study Group. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: A randomized controlled trial. Kidney Int. 2003 Dec;64(6):2222-8. doi: 10.1046/j.1523-1755.2003.00321.x.

Chesnaye NC, Schaefer F, Groothoff JW, et al. Mortality risk in European children with end-stage renal disease on dialysis. Kidney Int. 2016 Jun;89(6):1355-62. doi: 10.1016/j.kint.2016.02.016.

Vidal E, van Stralen KJ, Chesnaye NC, et al. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis Am J Kidney Dis. 2017 May;69(5):617-625. doi: 10.1053/j.ajkd.2016.09.024.

Chang HJ, Han KH, Cho MH, et al. Outcomes of chronic dialysis in Korean children with respect to survival rates and causes of death. Korean J Pediatr. 2014 Mar;57(3):135-9. doi: 10.3345/kjp.2014.57.3.135.

van de Luijtgaarden MWM, Noordzij M, Stel VS, et al. Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe. Nephrol Dial Transplant. 2011 Sep;26(9):2940-7. doi: 10.1093/ndt/gfq845.

Lukowsky LR, Mehrotra R, Kheifets L, Arah OA, Nissenson AR, Kalantar-Zadeh K. Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: A marginal structural model analysis. Clin J Am Soc Nephrol. 2013 Apr;8(4):619-28. doi: 10.2215/CJN.04810512.

Stokes JB. Peritoneal dialysis is not a superior therapy to hemodialysis: A comparison. Blood Purif. 2012;33(1-3):160-4. doi: 10.1159/000334159.

Noordzij M, Jager KJ. Patient survival on dialysis in Korea: A different story? Kidney Int. 2014 Nov;86(5):877-80. doi: 10.1038/ki.2014.194.

Mitsnefes MM, Laskin BL, Dahhou M, Zhang X, Foster BJ. Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990–2010. JAMA. 2013 May 8;309(18):1921-9. doi: 10.1001/jama.2013.4208.

NAPRTCS. 2011 Dialysis annual report. 2011. 74 p.

Alexander RT, Foster BJ, Tonelli MA, et al. Survival and transplantation outcomes of children less than 2 years of age with end-stage renal disease. Pediatr Nephrol. 2012 Oct;27(10):1975-83. doi: 10.1007/s00467-012-2195-8.

Mekahli D, Shaw V, Ledermann SE, Rees L. Long-term outcome of infants with severe chronic kidney disease. Clin J Am Soc Nephrol. 2010 Jan;5(1):10-7. doi: 10.2215/CJN.05600809.

Kari JA, , Gonzalez C, Ledermann SE, Shaw V, Rees L. Outcome and growth of infants with severe chronic renal failure. Kidney Int. 2000 Apr;57(4):1681-7. doi: 10.1046/j.1523-1755.2000.00013.x.

Shooter M, Watson A. The ethics of withholding and withdrawing dialysis therapy in infants. Pediatr Nephrol. 2000 Apr;14(4):347-51. doi: 10.1007/s004670050773.

Zurowska AM, Fischbach M, Watson AR, et al. Clinical practice recommendations for the care of infants with stage 5 chronic kidney disease (CKD5). Pediatr Nephrol. 2013 Sep;28(9):1739-48. doi: 10.1007/s00467-012-2300-z.

Pollack S, Eisenstein I, Tarabeih M, Shasha-Lavski H, Magen D, Zelikovic I. Long-term hemodialysis therapy in neonates and infants with end-stage renal disease: A 16-year experience and outcome Pediatr Nephrol. 2016 Feb;31(2):305-13. doi: 10.1007/s00467-015-3214-3.

van Stralen KJ, Borzych-Dużalka D, Hataya H. Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. Kidney Int. 2014 Jul;86(1):168-74. doi: 10.1038/ki.2013.561.

Foster BJ, Dahhou M, Zhang X, Platt RW, Hanley JA. Change in mortality risk over time in young kidney transplant recipients. Am J Transplant. 2011 Nov;11(11):2432-42. doi: 10.1111/j.1600-6143.2011.03691.x.

Hogan J, Couchoud C, Bonthuis M, et al. Gender disparities in access to pediatric renal transplantation in Europe: Data from the ESPN/ERA-EDTA registry. Am J Transplant. 2016 Jul;16(7):2097-105. doi: 10.1111/ajt.13723.

Saran R, Li Y, Robinson B, Abbott KC, et al. US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.12.014.

US Renal Data System. USRDS 2008 Annual Data Report, Volume 2: Atlas of end-stage renal disease in the United States. Available from: https://www.usrds.org/2008/view/esrd_00_intro.asp.

Carey WA, Martz KL, Warady BA. Outcome of patients initiating chronic peritoneal dialysis during the first year of life. Pediatrics. 2015 Sep;136(3):e615-22. doi: 10.1542/peds.2015-0980.

Sule S, Fivush B, Neu A, Furth S. Increased risk of death in pediatric and adult patients with ESRD secondary to lupus. Pediatr Nephrol. 2011 Jan;26(1):93-8. doi: 10.1007/s00467-010-1640-9.

Harambat J, van Stralen KJ, Espinosa L, et al. Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy. Clin J Am Soc Nephrol. 2012 Mar;7(3):458-65. doi: 10.2215/CJN.07430711.

Tsai H, Yang LY, Chin TW, et al. Outcome and risk factors for mortality in pediatric peritoneal dialysis. Perit Dial Int. 2010 Mar-Apr;30(2):233-9. doi: 10.3747/pdi.2008.00278.

Neu AM, Sander A, Borzych-Duzalka D, et al. Comorbidities in chronic pediatric peritoneal dialysis patients: A report of the international pediatric peritoneal dialysis network. Perit Dial Int. 2012 Jul-Aug;32(4):410-8. doi: 10.3747/pdi.2012.00124.

Shroff R, Rees L, Trompeter R, Hutchinson C, Ledermann S. Long-term outcome of chronic dialysis in children. Pediatr Nephrol. 2006 Feb;21(2):257-64. doi: 10.1007/s00467-005-2067-6.

Wood EG, Hand M, Briscoe DM, et al. Risk factors for mortality in infants and young children on dialysis. Am J Kidney Dis. 2001 Mar;37(3):573-9. doi: 10.1053/ajkd.2001.22083.

Ledermann SE, Scanes ME, Fernando ON, Duffy PG, Madden SJ, Trompeter RS. Long-term outcome of peritoneal dialysis in infants. J Pediatr. 2000 Jan;136(1):24-9. doi: 10.1016/S0022-3476(00)90044-1.

Hijazi R, Abitbol CL, Chandar J, Seeherunvong W, Freundlich M, Zilleruelo G. Twenty-five years of infant dialysis: A single center experience. J Pediatr. 2009 Jul;155(1):111-7. doi: 10.1016/j.jpeds.2009.01.007.

Wong CS, Gipson DS, Gillen DL, et al. Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis. 2000 Oct;36(4):811-9. doi: 10.1053/ajkd.2000.17674.

Ku E, Glidden DV, Hsu CY, Portale AA, Grimes B, Johansen KL. Association of Body Mass Index with patient-centered outcomes in children with ESRD. J Am Soc Nephrol. 2016 Feb;27(2):551-8. doi: 10.1681/ASN.2015010008.

Furth SL, Hwang W, Yang C, Neu AM, Fivush BA, Powe NR. Growth failure, risk of hospitalization and death for children with end-stage renal disease. Pediatr Nephrol. 2002 Jun;17(6):450-5. doi: 10.1007/s00467-002-0838-x.

Ku E, Fine RN, Hsu CY, et al. Height at first RRT and mortality in children. Clin J Am Soc Nephrol. 2016 May 6;11(5):832-9. doi: 10.2215/CJN.08250815.

Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: A reanalysis of the CANUSA study. J Am Soc Nephrol. 2001 Oct;12(10):2158-62.

Liao CT, Chen YM, Shiao CC, et al. Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysis. Nephrol Dial Transplant. 2009 Sep;24(9):2909-14. doi: 10.1093/ndt/gfp056.

Pruthi R, O'Brien C, Casula A, et al. UK renal registry 15th annual report: Chapter 4 demography of the UK paediatric renal replacement therapy population in 2011. Nephron Clin Pract. 2013;123 Suppl 1:81-92. doi: 10.1159/000353323.

Guzzo I, Mancini E, Wafo SK, Ravà L, Picca S. Residual renal function and nutrition in young patients on chronic hemodialysis. Pediatr Nephrol. 2009 Jul;24(7):1391-7. doi: 10.1007/s00467-009-1144-7.

Chadha V, Blowey DL, Warady BA. Is growth a valid outcome measure of dialysis clearance in children undergoing peritoneal dialysis? Perit Dial Int. 2001;21 Suppl 3:S179-84.

Borzych D, Rees L, Ha IS, et al; International Pediatric PD Network (IPPN). The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int. 2010 Dec;78(12):1295-304. doi: 10.1038/ki.2010.316.

Atkinson MA, Oberai PC, Neu AM, Fivush BA, Parekh RS. Predictors and consequences of higher estimated glomerular filtration rate at dialysis initiation. Pediatr Nephrol. 2010 Jun;25(6):1153-61. doi: 10.1007/s00467-010-1459-4.

Cooper BA, Branley P, Bulfone L, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med. 2010 Aug 12;363(7):609-19. doi: 10.1056/NEJMoa1000552.

Parekh RS, Carroll CE, Wolfe RA, Port FK. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr. 2002 Aug;141(2):191-7. doi: 10.1067/mpd.2002.125910.

US Renal Data System. USRDS 2008 Annual Data Report, Atlas of chronic kidney disease and end-stage renal disease in the United States. Available from: https://www.usrds.org/atlas11.aspx .

Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int. 2002 Feb;61(2):621-9. doi: 10.1046/j.1523-1755.2002.00156.x.

Luyckx VA, Naicker S, McKee M. Equity and economics of kidney disease in sub-Saharan Africa. Lancet. 2013 Jul 13;382(9887):103-4. doi: 10.1016/S0140-6736(13)60817-X.

Sinha A, Bagga A. Maintenance dialysis in developing countries. Pediatr Nephrol. 2015 Feb;30(2):211-9. doi: 10.1007/s00467-013-2745-8.

Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet. 2015 May 16;385(9981):1975-82. doi: 10.1016/S0140-6736(14)61601-9.






Copyright (c) 2019 KIDNEYS

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2019

 

   Seo анализ сайта